Carrier-mediated transport of oligopeptides in the human fibrosarcoma cell line HT1080.
暂无分享,去创建一个
T. Nakanishi | Y. Sai | Takuma Sasaki | I. Tamai | A. Tsuji | T. Sasaki
[1] T. Nakanishi,et al. Immunolocalization and pharmacological relevance of oligopeptide transporter PepT1 in intestinal absorption of β‐lactam antibiotics , 1996, FEBS letters.
[2] H. Yamamoto,et al. Sequence, tissue distribution and developmental changes in rat intestinal oligopeptide transporter. , 1996, Biochimica et biophysica acta.
[3] H. Saito,et al. Cloning and characterization of a rat H+/peptide cotransporter mediating absorption of beta-lactam antibiotics in the intestine and kidney. , 1995, The Journal of pharmacology and experimental therapeutics.
[4] V. Ganapathy,et al. Proton/peptide cotransporter (PEPT 2) from human kidney: functional characterization and chromosomal localization. , 1995, Biochimica et biophysica acta.
[5] M. Hediger,et al. Molecular cloning of PEPT 2, a new member of the H+/peptide cotransporter family, from human kidney. , 1995, Biochimica et biophysica acta.
[6] H. Higashida,et al. Functional expression of transporter for beta-lactam antibiotics and dipeptides in Xenopus laevis oocytes injected with messenger RNA from human, rat and rabbit small intestines. , 1995, The Journal of pharmacology and experimental therapeutics.
[7] M. Hediger,et al. Human Intestinal H+/Peptide Cotransporter , 1995, The Journal of Biological Chemistry.
[8] G. Amidon,et al. Peptide-based Drug Design, Controlling Transport and Metabolism , 1995 .
[9] T. Terasaki,et al. Functional expression of intestinal dipeptide/beta-lactam antibiotic transporter in Xenopus laevis oocytes. , 1994, Biochemical pharmacology.
[10] M. Romero,et al. Expression cloning of a mammalian proton-coupled oligopeptide transporter , 1994, Nature.
[11] H. Saito,et al. Dipeptide transporters in apical and basolateral membranes of the human intestinal cell line Caco-2. , 1993, The American journal of physiology.
[12] N. Tallada,et al. An Immunohistochemical Study , 1992 .
[13] V. Ganapathy,et al. Transport of peptides in renal brush border membrane vesicles. Suitability of 125I-labelled tyrosyl peptides as substrates. , 1991, Biochimica et biophysica acta.
[14] A. Dantzig,et al. Uptake of the cephalosporin, cephalexin, by a dipeptide transport carrier in the human intestinal cell line, Caco-2. , 1990, Biochimica et biophysica acta.
[15] K. Ramaswamy,et al. Characteristics of tripeptide transport in human jejunal brush-border membrane vesicles. , 1989, Biochimica et biophysica acta.
[16] A. Dantzig,et al. Carrier-mediated uptake of cephalexin in human intestinal cells. , 1988, Biochemical and biophysical research communications.
[17] T. Terasaki,et al. H+ gradient-dependent and carrier-mediated transport of cefixime, a new cephalosporin antibiotic, across brush-border membrane vesicles from rat small intestine. , 1987, The Journal of pharmacology and experimental therapeutics.
[18] M. Pinto,et al. Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture , 1983 .
[19] T Nakagawa,et al. A pharmacokinetic analysis program (multi) for microcomputer. , 1981, Journal of pharmacobio-dynamics.
[20] A. Kleinzeller,et al. Sugar transport in the LLC‐PK1 renal epithelial cell line: Similarity to mammalian kidney and the influence of cell density , 1980, Journal of cellular physiology.
[21] M. Rabinovitz,et al. Concentrative uptake of melphalan, a cancer chemotherapeutic agent which is transported by the leucine-preferring carrier system. , 1979, Biochemical and biophysical research communications.
[22] D. Vistica. Cytotoxicity as an indicator for transport mechanism: evidence that melphalan is transported by two leucine-preferring carrier systems in the L1210 murine leukemia cell. , 1979, Biochimica et biophysica acta.
[23] W. W. Nichols,et al. Characterization of a new human diploid cell strain, IMR-90. , 1977, Science.
[24] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[25] Suraiya Rasheed,et al. Characterization of a newly derived human sarcoma cell line (HT‐1080) , 1974, Cancer.
[26] F. Sirotnak,et al. Differential permeability and the basis for selective activity during methotrexate therapy of the l1210 leukemia. Abstr. , 1973 .
[27] I. Goldman. A model system for the study of heteroexchange diffusion: methotrexate-folate interactions in L1210 leukemia and Ehrlich ascites tumor cells. , 1971, Biochimica et biophysica acta.
[28] V. Oliverio,et al. Carrier-mediated transport of the folic acid analogue, methotrexate, in the L1210 leukemia cell. , 1968, The Journal of biological chemistry.
[29] H. Christensen,et al. An amino acid transport system of unassigned function in the Ehrlich ascites tumor cell. , 1965, The Journal of biological chemistry.